Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

For the other, it’s the latest trophy in what’s already a fairly gaudy collection. First, the milestone. Madison Keys has ...

Madison Keys attributed her breakthrough victory in securing her first Grand Slam title to extensive therapy, which she said ...